Takeda declines to respond to reports regarding sale of Osaka headquarters

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) declined

Read the full 67 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE